Results 11 to 20 of about 14,766 (232)
Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves’ Disease [PDF]
Endocrinology and Metabolism, 2022 Background Radioactive iodine (RAI) therapy is a successful therapeutic modality for Graves’ disease. However, RAI therapy can fail, and RAI therapy after antithyroid drugs (ATDs) has a lower remission rate.
Min Joo Kim +6 more
doaj +1 more source
Kuwait Journal of Science, 2021 Most of the radioisotopes that used in medical field, like examination and treatment studies, were produced by employing nuclear reactions. Within the process of a nuclear reaction, one of the most important parameter is the cross–section data which help
Hasan ÖZDOĞAN +2 more
doaj +1 more source
Hyperbaric oxygen therapy as a complementary treatment in neuroblastoma — a narrative review
Frontiers in Oncology, 2023 Neuroblastoma is the most frequently diagnosed cancer during the first year of life. This neoplasm originates from neural crest cells derived from the sympathetic nervous system, adrenal medulla, or paraspinal ganglia.
Diogo Alpuim Costa +14 more
doaj +1 more source
Efficacy and Safety of Long-Term Methimazole versus Radioactive Iodine in the Treatment of Toxic Multinodular Goiter [PDF]
Endocrinology and Metabolism, 2022 Background This study compared the degree of sustained control of hyperthyroidism in patients with toxic multinodular goiter (TMNG) treated with long-term methimazole (LT-MMI) or radioactive iodine (RAI).
Fereidoun Azizi +5 more
doaj +1 more source
Exploring CPP Enhanced Hypoxia Targeting: An Approach Using Radiolabeled 2-nitroimidazole TAT Conjugate. [PDF]
Drug Dev ResABSTRACT Mediated by their protein transduction domain, cell‐penetrating peptides (CPPs) have been widely explored for facilitating intracellular delivery of drugs and small molecules. In this study, a radiolabeled, 2‐nitroimidazole conjugated TAT (TAT ‐ transactivator of transcription) peptide was prepared and evaluated for targeting tumor hypoxia ...
Mittal S +4 more
europepmc +2 more sources
Life, 2021 Iodine-131 is increasingly used for diagnostic and therapeutic applications. The excretion of radioactive iodine is primarily through the urine. The safe disposal of radioactive waste is an important component of overall hospital waste management.
Tanate Suksompong +2 more
doaj +1 more source
Korean-specific iodine S values for use in internal dosimetry
Nuclear Engineering and Technology, 2023 The use of iodine S values derived using the International Commission Radiological Protection (ICRP) phantoms may introduce significant bias in internal dosimetry for Koreans due to anatomical variability.
Tae-Eun Kwon +2 more
doaj +1 more source
Future Pharmacology, 2022 Iodine is a highly reactive element with a single natural and stable isotopic form (127I). In the biosphere, it is one of the 30 essential elements for life, and its chemical speciation defines its availability and biological activities.
Astrid N. Espino-Vázquez +2 more
doaj +1 more source
Brazilian Journal of Radiation Sciences, 2022 Radioiodine therapy (RIT) is a complementary treatment to total thyroidectomy in differentiated thyroid cancer (DTC) patients. High levels of thyroid-stimulating hormone (TSH) are usually required in clinical practice to increase RIT efficacy. Suspension
Poliane A.L. Santos +8 more
doaj +1 more source
Radioimmunotherapy: A novel treatment of non-Hodgkin lymphoma [PDF]
Archive of Oncology, 2010 90Y-ibritumomab tiuxetan (Zevalin) and 131I-tositumomab (Bexxar) are current choices for radioimmunotherapy (RIT) of patients with follicular rituximab-relapsed or refractory CD20+ follicular B-cell NHL.
Petrović Tomislav, Mihailović Jasna
doaj +1 more source